FDA
-
-
-
-
-
-
-
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
-
-
-
-
-
-
-
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Talphera (TLPH)
-
-
-
-
-
-
-
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
-
-
-
-
-
-
-
Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Talphera (TLPH) Announces Board Changes
-
-
-
-
323,147 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

